Xonar SRL
The score of Xonar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +49 % Total assets +129 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Xonar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
Xonar's financial analysis
- Solvency35.9%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Xonar
Xonar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0793.600.649
- VAT number
- BE0793600649
- Peppol
- Registered · 0208:0793600649 · as of 04 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Nov 2022
- Registered office
- 2580 Putte
- Latest accounts
- 2025 · filed on 13 Jul 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Xonar (SRL) has been based in Putte since 2022, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 7,077 € and equity of 51,733 €; its revenue is not published. Its solvency stands at 35.9%, below the median of its sector (56.0%).
Companies similar to Xonar
Companies in the same business, of comparable size and area, outside its group.
- Moonwave Research and experimental development on natural sciences and engineering Zemst · balance sheet 196,577 €
- Make IT Work Consulting Manufacture of basic pharmaceutical products Hamois · balance sheet 220,980 €
- Qualliance Pharma All other professional, scientific and technical activities n.e.c. Oud-Heverlee · balance sheet 161,218 €
- Clinical Research Vanackere Manufacture of basic pharmaceutical products Tielt-Winge · balance sheet 263,927 €
- Scandium Other business support service activities n.e.c. Tielt · balance sheet 200,459 €
- Dicover All other professional, scientific and technical activities n.e.c. Diest · balance sheet 152,875 €
- C D C Construct Other specialised construction activities n.e.c. Brussels · balance sheet 134,681 €
- En línea Other specialised construction activities n.e.c. Beringen · balance sheet 98,769 €
Frequently asked questions about Xonar
What is the revenue of Xonar?
Xonar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Xonar?
In Belgium, the VAT number is the company number prefixed with BE: BE0793600649 for Xonar, if the company is VAT-registered. Its company number (CBE) is 0793.600.649.
Where is the registered office of Xonar?
According to the CBE register, the registered office of Xonar is in 2580 Putte.
What is the equity of Xonar?
At the close of the 2025 financial year, the equity of Xonar amounts to 51,733 €, a solvency of 35.9% of total assets.
Who manages Xonar?
The register lists 1 active mandates at Xonar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Xonar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →